🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/07/2005 | 25,79 | 27,14 | 25,30 | 27,14 | +5,68% | 7,11% | 164.575 |
| 01/07/2005 | 26,39 | 26,39 | 25,27 | 25,68 | -1,29% | 4,26% | 73.070 |
| 30/06/2005 | 26,13 | 26,61 | 25,68 | 26,01 | -0,14% | 3,58% | 149.079 |
| 29/06/2005 | 26,28 | 26,58 | 25,49 | 26,05 | -0,57% | 4,13% | 360.942 |
| 28/06/2005 | 25,27 | 26,24 | 24,89 | 26,20 | +5,42% | 5,33% | 340.638 |
| 27/06/2005 | 23,96 | 25,19 | 23,24 | 24,85 | +3,75% | 8,13% | 233.557 |
| 24/06/2005 | 22,08 | 23,96 | 22,08 | 23,96 | +8,47% | 8,47% | 170.292 |
| 23/06/2005 | 23,02 | 23,02 | 22,08 | 22,08 | -3,91% | 4,06% | 81.245 |
| 22/06/2005 | 22,57 | 22,98 | 22,31 | 22,98 | +3,02% | 2,98% | 89.768 |
| 21/06/2005 | 22,42 | 23,24 | 22,23 | 22,31 | -0,83% | 4,51% | 107.695 |
| 20/06/2005 | 22,94 | 23,28 | 22,12 | 22,50 | -2,75% | 5,06% | 120.118 |
| 17/06/2005 | 22,79 | 23,32 | 22,20 | 23,13 | +2,32% | 4,93% | 198.264 |
| 16/06/2005 | 21,34 | 22,83 | 21,34 | 22,61 | +5,96% | 7,02% | 154.823 |
| 15/06/2005 | 21,45 | 21,60 | 21,07 | 21,34 | -0,17% | 2,44% | 183.971 |
| 14/06/2005 | 21,93 | 22,08 | 21,37 | 21,37 | -1,38% | 3,24% | 140.423 |
| 13/06/2005 | 21,90 | 22,08 | 21,67 | 21,67 | -1,86% | 1,88% | 90.222 |
| 10/06/2005 | 21,82 | 22,46 | 21,82 | 22,08 | +1,03% | 2,92% | 106.573 |
| 09/06/2005 | 21,67 | 22,27 | 21,45 | 21,86 | +0,52% | 3,80% | 508.685 |
| 08/06/2005 | 22,20 | 22,35 | 21,37 | 21,75 | -1,19% | 4,38% | 206.947 |
| 07/06/2005 | 21,71 | 22,76 | 21,63 | 22,01 | +1,20% | 5,17% | 263.934 |
| 06/06/2005 | 22,12 | 22,27 | 21,75 | 21,75 | -2,84% | 2,37% | 192.146 |
| 03/06/2005 | 22,38 | 22,72 | 22,05 | 22,38 | -1,32% | 3,01% | 168.288 |
| 02/06/2005 | 22,57 | 22,83 | 22,23 | 22,68 | +1,00% | 2,65% | 186.536 |
| 01/06/2005 | 21,82 | 22,50 | 21,82 | 22,46 | +2,74% | 3,09% | 242.454 |
| 31/05/2005 | 22,12 | 22,38 | 21,82 | 21,86 | -2,50% | 2,54% | 81.753 |
| 27/05/2005 | 22,27 | 22,46 | 22,08 | 22,42 | +0,00% | 1,68% | 55.143 |
| 26/05/2005 | 21,86 | 22,46 | 21,71 | 22,42 | +2,22% | 3,42% | 167.139 |
| 25/05/2005 | 22,27 | 22,42 | 21,67 | 21,93 | -0,68% | 3,36% | 180.257 |
| 24/05/2005 | 22,20 | 22,38 | 21,56 | 22,08 | -0,34% | 3,71% | 209.726 |
| 23/05/2005 | 22,23 | 22,46 | 21,19 | 22,16 | +0,68% | 5,72% | 694.580 |